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Background: Porphyromonas gingivalis is a gram-negative bacterium that causes destructive chronic periodontitis.
In addition, this bacterium is also involved in the development of cardiovascular disease. The aim of this study was
to investigate the effects of P. gingivalis infection on gene and protein expression in human aortic smooth muscle
cells (AoSMCs) and its relation to cellular function.
Results: AoSMCs were exposed to viable P. gingivalis for 24 h, whereafter confocal fluorescence microscopy was
used to study P. gingivalis invasion of AoSMCs. AoSMCs proliferation was evaluated by neutral red assay. Human
genome microarray, western blot and ELISA were used to investigate how P. gingivalis changes the gene and
protein expression of AoSMCs. We found that viable P. gingivalis invades AoSMCs, disrupts stress fiber structures
and significantly increases cell proliferation. Microarray results showed that, a total of 982 genes were identified as
differentially expressed with the threshold log2 fold change > |1| (adjust p-value <0.05). Using bioinformatic data
mining, we demonstrated that up-regulated genes are enriched in gene ontology function of positive control of
cell proliferation and down-regulated genes are enriched in the function of negative control of cell proliferation.
The results from pathway analysis revealed that all the genes belonging to these two categories induced by
P. gingivalis were enriched in 25 pathways, including genes of Notch and TGF-beta pathways.
Conclusions: This study demonstrates that P. gingivalis is able to invade AoSMCs and stimulate their proliferation.
The activation of TGF-beta and Notch signaling pathways may be involved in the bacteria-mediated proliferation
of AoSMCs. These findings further support the association between periodontitis and cardiovascular diseases.
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Porphyromonas gingivalis, a gram-negative asaccharoly-
tic bacterium, has been recognized as a key causative
microbe in the pathogenesis of destructive chronic peri-
odontitis. In addition, P. gingivalis is able to gain access
into the bloodstream and attach to the vascular wall [1].
A great number of epidemiological studies indicate that* Correspondence: boxi.zhang@oru.se
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reproduction in any medium, provided the orthere is an association between P. gingivalis infection
and cardiovascular disease [2,3] and DNA of P. gingivalis
has been detected in coronary stenotic artery plaques of
myocardial infarction patients [4]. Furthermore, many
in vitro and animal experiments support the connection
between P. gingivalis infection and the pathogenesis
of atherosclerosis. We have previously reported that P.
gingivalis induces neutrophil ROS-production, sensitizes
platelet for epinephrine, down-regulates immune response
of T-cells and converts LDL to an atherogenic form [5-8].Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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human subjects, in vitro studies have shown that P.
gingivalis can invade different types of human vascular
cells, including umbilical vein endothelial cells (HUVECs)
[9], coronary artery smooth muscle cells [10], and aortic
smooth muscle cells [11].
Virulence factors of P. gingivalis, such as lipopolysaccha-
rides (LPS), fimbriae, toxic products of metabolism and
proteases have been identified to activate defensive re-
sponse processes of host cells, leading to release of inflam-
matory mediators and chronic inflammation [12]. During
the last decades, inflammation has been attributed as the
key factor beneath atherosclerosis which was formerly con-
sidered as a bland lipid storage disease [13,14]. The devel-
opment of atherosclerosis is due to a complex interaction
between multiple risk factors including hypertension, high
plasma levels of inflammatory mediators, and hypercholes-
terolemia [15]. It is possible that P. gingivalis, directly or
indirectly, induces and supports inflammatory processes
in the vessel wall. In atherogenesis, different cell types,
including macrophages, monocytes, platelets, endothelial
cells, and smooth muscle cells (SMCs), are involved [16].
Vascular smooth muscle cells (VSMCs) are one of the
fundamental components of the vessel wall and are in-
volved in atherogenesis, plaque progression and rupture
[17]. During atherogenesis, the VSMCs undergo pheno-
typic modulation from a quiescent to a synthetic state
that is activated by various mediators, such as platelet-
derived growth factor, and migrate from the media into
the intima. In the intima, VSMCs enhance synthesis of
extracellular matrix (ECM) and proliferate under the
stimulation by specific cytokines. The proliferation of
VSMCs and the production of ECM contribute to the
plaque growth and the development of fibrotic cap. Fur-
thermore, the production of ECM facilitates accumula-
tion of modified low-density lipoproteins (LDL) through
binding to proteoglycans. After binding to proteoglycan,
LDL is oxidized, which further activates VSMCs to
produce more sulfated proteoglycans and arrest more
LDL [18].
Up to now, no study has been conducted to elucidate
the possible signaling mechanisms involved in VSMCs
challenge with live P. gingivalis. The aim of this study is
to investigate effects of P. gingivalis infection on gene
and protein expression and its relation to cellular func-
tion of human aortic smooth muscle cells in order to
clarify the association between periodontitis and cardio-
vascular disease.
Results
P. gingivalis invades AoSMCs
Using confocal fluorescence microscopy, we found that P.
gingivalis at the MOI of 10 invaded AoSMCs and after 24
hours showedmainly at perinuclear localization (Figure 1C).Compared with control samples (Figure 1A), AoSMCs in-
fected by P. gingivalis demonstrated a disruption of stress
fibers and a relocalization of F-actin to the cell periphery
(Figure 1B). The 3D images (Figure 1D-G) show that P.
gingivalis is able to invade AoSMCs.
P. gingivalis increase AoSMCs proliferation
The proliferative effects of viable P. gingivalis on
AoSMCs were examined with the neutral red assay. We
found that AoSMCs, after challenging with P. gingivalis
for 24 h significantly increased the subsequent prolifera-
tion in 0.5% serum after 24 h, 48 h, and 72 h, compared
with the unstimulated cells, with a maximal effect after
48 h (Figure 2).
P. gingivalis changes gene expression in AoSMCs
A difference in the expression of specific genes in AoSMCs
induced by P. gingivalis, was identified by setting the
threshold of log fold change (logFC) above |1| with adjust
p- value (Benjamini-Hochberg) < 0.05. Through analyzing
mRNA originated from 4 independent experiments, a total
of 982 genes were identified as differentially expressed,
in which 438 genes were up-regulated and 544 genes
were down-regulated, compared to the uninfected control
group. A whole list of differentially expressed genes is
provided in supplemental material (Additional file 1:
Table S1). The whole data were visualized by CIRCOS
[19] (Additional file 2: Figure S1).
For the differentially expressed genes, we found that
28 up-regulated genes (Additional file 3: Table S2) were
significantly related to the GO term of positive regula-
tion of cell proliferation (GO: 0008284, p-value < 1.6E-6);
21 down-regulated genes (Additional file 4: Table S3)
were related to the GO term of negative regulation of
cell proliferation (GO: 0008285, p-value < 2.5E-3). The
functional interaction network for the genes involved in
these two categories is shown in (Figure 3A).
Pathway analysis of genes regulated by P. gingivalis
using SPIA
The 28 up-regulated genes related to the GO term of posi-
tive regulation of cell proliferation and 21 down-regulated
genes related to the GO term of negative regulation of cell
proliferation were inserted in the R platform and analyzed
using SPIA package. Significant pathways were picked out
by combining the fold change of the genes and pathways
topology information. For each pathway, a novel param-
eter, termed perturbation, was measured by the position of
specific genes within the 134 KEGG pathways. Genes with
a high hierarchical position would have more power to de-
termine whether the genes are enriched in a certain path-
way. For a total of 49 genes, SPIA analysis showed that
these genes were enriched in 25 pathways (FDR < 0.05), in
which, 7 pathways were considered significant with a level
Figure 1 P. gingivalis invades AoSMCs and changes the F-actin distribution. AoSMCs were cultured on glass coverslips in multiwall plates
stimulated with (B and C) or without (A) FITC-stained P. gingivalis (green arrows) for 24 h and then stained for F-actin (red arrows) and nucleus
(blue arrows). The cells were mounted upside-down and visualized by scanning confocal laser microscopy. The 3D images (D-G) are shown
by different combination of stained components: F-actin and nucleus (D); F-actin and FITC-stained P. gingivalis (E); nucleus and FITC-stained
P. gingivalis (F); F-actin, nucleus and FITC-stained P. gingivalis (G).
Figure 2 P. gingivalis increases AoSMCs proliferation. The neutral
red assay was used to analyze changes in AoSMCs growth after
challenge with P. gingivalis at the concentration of 10MOI for 24 h in
the absence or presence of viable P. gingivalis. The results are presented
as the mean ± SEM of four separate experiments. *, p < 0.05.
**, p < 0.005. n = 4.
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ways are listed in supplemental material (Additional file 5:
Table S4).Validation of microarray data in Notch and
TGF-beta pathway
In this study, we focused on TGF-beta and Notch path-
way that are known to be involved in the proliferation of
AoSMCs. Several differentially expressed genes in these
two pathways were picked out and validated by qPCR.
The gene TGF- β1, which belong to the TGF-beta path-
way, showed up-regulation by P. gingivalis in both the
microarray and the qRT-PCR assay (Figure 4A), as well as
in protein level (Figure 4H). We further validated the gene
of connective tissue growth factor (CTGF), which has
been indicated to cooperate with TGF-beta to induce
fibrosis [20]. The qPCR analysis of the CTGF gene
(Figure 4B) confirms the P. gingivalis-mediated up-
regulation of this gene and complements the results from
the microarray. The third gene selected for validation of
microarray data was SMAD family member 3 (SMAD3)
(Figure 4C), which has previously been shown to be a
signaling components of the TGF-beta superfamily [21].
In Notch pathway, we focused on two genes, Notch1
Figure 3 (See legend on next page.)
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Figure 3 The protein-protein interaction network and SPIA analysis of the 28 up-regulated genes related to positive regulation of cell
proliferation and 21 down- regulated genes related to negative control of cell proliferation. The network (A) was mapped using STRING,
and the confidence parameter was set as 0.15. Lines between proteins stand for possible interactions, and are color-coded based on the type of
interaction. In SPIA analysis (B), X-axis indicates probability to observe differentially expressed genes on the pathway; y-axis refers to the probability to
observe perturbation of genes within pathways. Each number refers to a KEGG pathway ID. Pathways above the blue line are significant at 5% after
FDR correction; those above the red lines are significant at 5% after Bonferroni correction. 49 genes were analyzed by SPIA analysis. The Notch pathway
is shown as a yellow dot and TGF-beta pathway is shown as a green dot.
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YRPW motif protein 1 (HEY1) (Figure 4E). Notch1, which
functions as a membrane-bound signaling molecule and
takes part in various defense and immune responses,
showed an up- regulation in P. gingivalis-infected AoSMCs
in both the microarray and qPCR results. This increase in
gene expression was associated with an elevation in
protein level, using western blot (Figure 4G and 4F). HEY1
is a downstream gene of Notch1 in the Notch pathway.
We found that P. gingivalis increased the expression of this
gene in AoSMCs more than 10 fold, both in the qPCR and
the microarray.
Discussion
Many risk factors have been identified to contribute to the
development of atherosclerosis and cardiovascular disease.
Classical risk factors include high circulating levels of LDL,
smoking, and low physical activity. However, up till 50% of
patients with cardiovascular disease do not possess any of
the classical risk factors [22]. It is believed that the immune
system participates in the development of atherosclerosis
and inflammation and infection have been considered as
key factors [23]. Increasing evidence has implicated that
specific microorganisms, including the periodontal patho-
gen P. gingivalis, are involved in the progression of athero-
sclerosis. In this study, we focused on the interaction
between P. gingivalis and vascular smooth muscle cells.
We found, by using confocal microscopy 3D analysis, that
P. gingivalis invades AoSMCs, reorganizes the actin cyto-
skeleton and causes AoSMCs proliferation, the latter con-
sidered as a key process in atherosclerosis. Although,
proliferative effects of P. gingivalis infection of SMCs have
previously been reported [24], the mechanisms involved
are uncertain. We used a comprehensive bioinformatics
analysis and studied the gene expression profiling of
smooth muscle cells after challenge with viable P. gingivalis,
which gave us an insight of the effects of this periodontal
bacterium on the vessel wall.
By using microarray analysis, we found that 982 genes
were differentially expressed in P. gingivalis–infected
AoSMCs, compared to uninfected control samples. In
order to clarify whether genes contributing to cell prolifera-
tion are involved during P. gingivalis infection, gene ontol-
ogy analysis was performed. We found that differentiallyexpressed genes were significantly enriched in the GO cat-
egories, including positive regulation of cell proliferation
for up-regulated genes and negative regulation of cell prolif-
eration for down-regulated genes. In these two categories,
growth factors and their receptors were enriched, such as
heparin-binding growth factor 1 (FGF1), platelet-derived
growth factor subunit A (PDGFA), fibroblast growth factor
receptor 3 (FGFR3) and beta-type platelet- derived growth
factor receptor (PDGFRB). Interestingly, we also found a
great number of genes belonging to Notch and TGF-beta
pathway. The result of SPIA analysis showed that the differ-
entially expressed genes belonging to these two GO cat-
egories are enriched in NOTCH and TGF-beta pathway, so
as the total up-regulated genes by P. gingivalis treatment
(Additional file 6: Figure S2). Among the genes that were
differently expressed by P. gingivalis, GUCY1A3 (36.8 fold)
and GUCY1B3 (36.5 fold) are the top 2 up-regulated genes.
Both genes are associated with components belong to the
downstream of Notch signaling pathway [25]. Furthermore,
within Notch signaling pathway, P. gingivalis up-regulated
three Notch receptors (Notch1, Notch3, Notch4). Notch
signaling pathway regulates organogenesis and critical cel-
lular processes such as cardiomyocyte proliferation and dif-
ferentiation during heart development [26]. Notch1 has
been shown to play an important role in SMCs prolifera-
tion, migration and survival. Neointimal formation in
Notch1 general heterozygous knockout (Notch1 +/-) mice
was remarkably suppressed compared to wild type mice
[27]. Indeed, Notch signaling also plays important role in
the pathogenesis of common vascular proliferative syn-
dromes including atherosclerosis and restenosis [28]. In
addition, we found that the bHLH genes of the Hes/Hey
families also were highly induced by P. gingivalis, including
HES1 (35.0 fold), HES4 (5.8 fold), HES5 (23.5 fold), HEYL
(29.6 fold), HEY1 (35.0 fold), and HEY2 (26.1 fold). Hes/
Hey familiy is identified as the target genes of various
Notch receptors [29,30]. In correlation, lipopolysaccharide
from P. gingivalis has been shown to activate Notch1 sig-
naling and induce the production of HES1 and HEY1 [31].
Other target genes like JAG1, SDC2 and SNAI2 were also
demonstrated to be up-regulatied [32-34]. All these results
complement to the SPIA analysis, further demonstrating
that the Notch pathway is significantly activated in
AoSMCs in response to P. gingivalis.
Figure 4 The expression of selected genes and proteins in AoSMCs stimulated with P. gingivalis. Quantitative real-time PCR results demonstrate
relative transcription for TGF-β1 (A), CTGF (B), SMAD3 (C), NOTCH1 (D), and HEY1 (E) of AoSMCs stimulated (P. g) or unstimulated (control) with
P. gingivalis at 10 MOI for 24 h. All these results were normalized by the gene expression level of the house-keeping gene GAPDH. Representative western
blot showing NOTCH1 protein expression levels of AoSMCs exposed to P. gingivalis at 8 and 10 MOI (F). Quantification of NOTCH1 protein expression
levels by densitometry is shown in (G). NOTCH1 density signals were normalized to GAPDH signal values. P. gingivalis resulted in a dose-dependent
(MOI 8 and 10) induction of TGF-β1 protein expression (H). *, p < 0.05; **, p < 0.005; ***, p < 0.0001. A, n = 10; B-E, n = 6; F, G, n = 3; H, n = 3-4.
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cantly activated in AoSMCs by P. gingivalis. TGF-beta can
cooperate with Notch pathway in the regulation of SMCsdifferentiation [35]. Although the growth of normal hu-
man SMCs is inhibited by TGF-beta, the growth of cells
isolated from human atherosclerotic lesions is markedly
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an increase in collagen synthesis [36]. In consent, previous
reports have revealed in vivo, using balloon injury models,
that increased levels of TGF-β1 signaling enhance the in-
timal thickness and induce SMCs proliferation and differ-
entiation [37]. Through the activation of TGF-beta, the
glycosaminoglycan synthetic machinery of AoSMCs can
be modulated and bind more LDL [38]. We also found
that the gene of Smad3 is highly induced by P. gingivalis
and when Smad3 levels are elevated, TGF-beta stimulates
SMCs to proliferate and accelerate neointimal formation
[39,40]. In order to understand the association between
TGF-β1 and Smad3 and how they interact with other dif-
ferentially expressed genes, we have visualized gene-gene
interactions by GeneAnswers package (Figure 5). We
found that there is a direct connection between TGF- β1
and Smad3 through the TGF receptor type I (TGFRI). Ac-
tivation of the TGF-beta pathway leads to binding of TGF-
beta to TGF receptor type II (TGFRII), and then, this
complex binds to TGFRI, resulting in TGFRI phosphoryl-
ation [41] and activation of the downstream Smad path-
way. The Smad pathway regulates the transcription of
several target genes [42], such as CTGF and Elastin (ELN)
(Figure 6). The results from GeneAnswers package also
showed there is a crosstalk between smad3 and Notch1.Figure 5 The graph of gene-gene association among TGF-β1, Smad3
P. gingivalis. Each dot refers to one gene and the color of dots refers to th
up-regulated genes. Green dots indicate down-regulated genes. The deepeThis connection is due to the direct protein–protein inter-
action between Notch intracellular domain (NICD) and
Smad3 [43]. Due to the fact that the TGF- beta and Smad3
are over-expressed after arterial injury, as well as the acti-
vation of Notch pathway, we suggest that these signaling
mechanisms are involved in P. gingivalis- induced differ-
entiation and proliferation of AoSMCs.Conclusions
In summary, this study suggests that the periodontal
pathogen P. gingivalis stimulates AoSMCs proliferation
through activation of the TGF-beta and Notch signaling
pathways and thus enhances the progression of athero-
sclerosis, which further supports an association between
periodontitis and cardiovascular disease.Methods
Culture of SMCs
Human primary AoSMCs (Invitrogen, Stockholm, Sweden)
were cultured in 231 smooth muscle cell culture medium
(Gibco, Carlsbad, CA) containing recommended supple-
ments. The cells were cultured in 75 cm [2] explants cul-
ture flasks (TPP, Trasadingen, Switzerland) and placed in
cell culture incubator at 37°C with 5% CO2 and 95% air.and other differentially expressed genes in AoSMCs exposed to
e log fold change of the gene expression level. Red dots indicate
r is the color, the bigger fold change of the genes.
Figure 6 TGF-β and NOTCH activation in AoSMCs stimulated with P. gingivalis. Treatment of AoSMCs with viable P. gingivalis, increases the
mRNA expression level of TGF-beta. TGF-beta is secreted as a latent complex which can be activated by a number of agents. The activation of
TGF-beta interacts with TGFRII and this complex further phosphorylates TGFRI to activate the Smad pathway by phosphorylation at the carboxyl
terminus. During this process, Smad anchor for receptor activation (SARA) can facilitate TGF-beta receptor complex to bind to R-Smads (Smad 2/3).
Once the R-Smads being phosphorylated, they bind to Co-Smads to form a complex which go into nucleus and regulates the transcription of several
targets genes involved in atherosclerosis. Beside this, TGF-beta and NOTCH pathway can collaborate with each other by direct interaction between
Smad3 and NICD.
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5-10 were used in this study.
Porphyromonas gingivalis
The P. gingivalis ATCC 33277 (American Type Culture
Collection, Manassas, VA) were cultured in fastidious an-
aerobe broth (29.7 g/liter, pH 7.2) in an anaerobic cham-
ber (80% N2, 10% CO2, and 10% H2, 37°C) (Concept 400
Anaerobic Workstation; Ruskinn Technology Ltd., Leeds,
United Kingdom). The bacteria were harvested after 3 to 4
days by centrifugation for 10 min at 10000 rpm, followed
by washing and resuspension in Krebs-Ringer-Glucose
(KRG) buffer. The supernatant was removed from bacteria
pellet, which was then washed with KRG buffersupplemented with 1.1 mM CaCl2. The concentration of
P. gingivalis was measured by counting CFU (Colony-
forming unit) of different dilutions of bacteria on blood
agar after 5 to 7 days. The optical density (OD) at 600 nm
of the bacteria suspension was measured with a spectro-
photometer (BioPhotometer plus) (Eppendorf AG, Ham-
burg, Germany) to correlate to the concentration (CFU/
ml) of the bacteria.
Bacterial inoculation
AoSMCs were dissociated using 3ml trypsin/EDTA so-
lution (Gibco, Carlsbad, CA) and transferred to 12 ml
microcentrifuge tube, centrifuged at 14,000 rpm for 4min,
re- suspensed in fresh medium, and seeded at a density of
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gen (Gibco, Carlsbad, CA). Cells were serum starved for
24 hour using DMEM medium (Gibco, Carlsbad, CA)
with 0.5% FBS (Sigma, St. Louis, MO), 2mM L-glutamin
(Gibco, Carlsbad, CA) and antibiotics (Gibco, Carlsbad,
CA). After 24 hour serum starvation, medium were dis-
carded and AoSMCs washed and resuspended with fresh
DMEM medium. The AoSMCs were challenged with vi-
able P. gingivalis with the concentration of 8 or 10 MOI
for 24 hours.
Confocal fluorescence microscopy
P. gingivalis was incubated with 2 g/ml fluorescein iso-
thiocyanate (FITC) (Sigma, St. Louis, MO), dissolved in
carbonate-bicarbonate buffer (pH 9.2), for 1 hour at
room temperature with gentle agitation in dark. After
wash twice in PBS, the concentration of bacteria was
measured by OD at 600 nm. The viability of FITC-
labeled P. gingivalis was confirmed by viable count ana-
lysis. AoSMCs were cultured on type I collagen coated
glass cover slips, in 6 well cell culture plates. After
serum starvation, cells were challenged with FITC-
labeled P. gingivalis (10 MOI) for 24 hour, followed by
fixation with 4% paraformaldehyde (PFA) for 30 minutes
at room temperature. The F-actin of the cells was
stained by incubation with Alexa Fluor 594 Phalloidin
(Molecular Probes, Eugene, OR) in the dark for 30 mi-
nutes. The nucleus was stained using 4’6-diamidino-
2-phenylindole (DAPI) (Sigma, St. Louis, MO) for 10
minutes in dark, followed by washing twice with PBS. The
cover slips were dried in room air, and then, mounted onto
microscope glass slides using mounting medium (Pertex;
Histolab Products, Gothenburg, Sweden). A scanning con-
focal laser microscope, (FluoViewTM FV1000 Confocal
Laser Scanning Biological Microscope; Olympus, Hamburg,
Germany) was used to visualize the stained cells. The im-
ages were captured in 60× objective using oil immersion
lens, whereafter the images were processed using FV10-
ASW viewer 2.0 software (Olympus, Hamburg, Germany).
The 3D images were created by stacking 77 pieces of slices
which were captured every 0,1 μm over each other.
Proliferation assay
In order to investigate the proliferation responses,
serum-starved AoSMCs were incubated with viable P.
gingivalis for 24 h (see above), whereafter the medium
was replaced with medium containing 0.5% FBS for 24 h,
48 h and 72 h. The proliferation responses were moni-
tored using the neutral red assay described by Guillermo
et al [44]. Briefly, neutral red (Sigma-Aldrich, St. Louis,
MO) was dissolved in the cell culture medium at the
concentration of 40 μ g/ml and incubated overnight at
37°C. The medium of the samples was aspirated out and
cells were washed twice with PBS, whereafter 1 ml ofneutral red medium (40 μ g/ml) was added to each well
of the plate. After 2 h incubation at 37°C, the neutral
red medium was removed. The neutral red was extracted
from the cells by adding 1ml destain solution (50% of
96% ethanol, 49% MQ water, 1% glacial acetic acid),
followed by measurements of OD absorbance at 540 nm
in a microtiter plate reader. (SpectraMax 340, Micro-
plate Reader; Molecular Devices Corp., Sunnyvale, CA).Microarray gene expression analysis
After 24 hour incubation with P. gingivalis, cells were
harvested and RNA was extracted from the cells accord-
ing to the protocol of RNeasy Kit (Omega Bio-Tek,
Norcross, GA). In order to minimize experimental and
technical errors in our array analysis, we produced 4
biological replications and swapped the dyes for two of
the arrays. The quality of RNA was evaluated using
the Agilent Bioanalyze (Agilent, Santa Clara, CA) and
nanodrop 2000 (Thermo, Wilmington, DE). The RNA
samples were hybridized and scanned by Agilent Micro-
array Scanner (Agilent, Santa Clara, CA). Agilent human
whole genome 4x44 arrays (Agilent, Santa Clara, CA)
and protocols were used for gene expression profiling
analysis. For gene expression level investigations, i.e. the
analysis of whole- gene variation with genotype, the .txt
files obtained from Feature Extraction software (version
6.1.1, Agilent Technologies) was preprocessed using
limma package [45] offered by Bioconductor repository
[46]. The raw data were normalized and log2- trans-
formed. Linear model was tried to identify differentially
expressed genes. Fold change and adjusted p-value (false
discovery rate, FDR) was calculated and genes with fold
change ≥ 2 and FDR < 0.05 were considered as differen-
tially expressed genes and were used for further analysis
in this study. In order to characterize gene functions re-
lated to proliferation, up-regulated and down- regulated
differentially expressed genes were input into DAVID
[47], separately, and the functional interaction networks
was built using STRING [48].KEGG pathway enrichment analysis by Signaling Pathway
Impact Analysis (SPIA)
Signaling Pathway Impact Analysis (SPIA) algorithm
[49,50] was applied to find the specific KEGG signaling
pathways (database downloaded from KEGG’s website
on: 03/21/2012) that included the differential expressed
genes related to cell proliferation. SPIA integrates the in-
formation from all genes that were considered to be dif-
ferentially expressed and the vector of log2 fold change
of each gene to do the enrichment analysis. 134 path-
ways at this version are looked through to find signifi-
cantly (false discovery adjusted global p- value cut-off of
0.1) modulated pathways.
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cDNA were made using High Capacity cDNA Reverse
Transcription Kits (PERkin- Elmer Applied Biosystems,
Foster City, CA) following the recommended protocol.
Quantitative real-time PCR was performed with an ABI
Prism 7900HT Sequence Analyzer using the manu-
facturer’s recommended protocol (PERkin-Elmer Applied
Biosystems, Foster City, CA) to validate differentially
expressed genes of interest. The PCR primer and probes
(PERkin-Elmer Applied Biosystems, Foster City, CA)
for TGF-β1 (Hs00998133_m1), CTGF (Hs01026927_g1),
Notch1 (Hs01062014_m1), HEY1 (Hs01114113_m1), and
SMAD3 (Hs00969210_m1) were applied in this study and
GAPDH was used for normalization.
Western blot assay
Proteins were extracted from AoSMCs, which had been un-
stimulated or stimulated for 24 h with viable P. gingivalis,
using RIPA Buffer (Sigma-Aldrich, St. Louis, MO) con-
taining a protease inhibitor cocktail (Sigma-Aldrich, St.
Louis, MO). The total protein concentration was deter-
mined using the BCA protein assay kit (Thermo Scientific,
Rockford, USA). An equal amount of each sample (20 μg)
was electrophoresed on 10% SDS–PAGE and transferred
onto nitrocellulose membrane (Bio-Rad, Hercules). After
blocking in non-fat dried milk, membranes were probed
overnight at 4°C using rabbit polyclonal anti-cleaved
Notch1 (Novus Biologicals, Cambridge, UK) in 1: 2,000 di-
lution. Rabbit polyclonal anti-GAPDH in 1:15,000 (Santa
Cruz Biotechnology, Dallas, Texas) dilution was used as
loading control. Blots were then incubated with anti-
rabbit IgG (Santa Cruz Biotechnology, Dallas, Texas) and
visualized using an enhanced chemiluminescence system
(GE Healthcare Biosciences, Pittsburgh, PA) and exposed
to Hyperfilm enhanced chemiluminescence (GE Health-
care Biosciences, Pittsburgh, PA). Densitometric analysis
was performed using NIH software package Image J
(ImageJ 1.32j; NIH, Bethesda, MD).
Enzyme-linked immunosorbent assay (ELISA)
The supernatants from AoSMCs challenged for 24 h with
different concentrations of viable P. gingivalis were col-
lected and centrifugated at 1500 × g for 5 min at 4°C,
whereafter, the supernatants were stored at −80°C until
use. ELISA was performed using supernatants to quantify
TGF-β1 (BD OptEIA Set Human TGF-β1, BD Biosci-
ences, USA) according to the manufacturer's instructions.
Statistical analysis
The Benjamini-Hochberg procedure was used to find
the differentially expressed genes in microarray data.
Student's t-test was used for statistical comparisons of
two groups and one-way ANOVA with appropriate post-tests was used for more than two groups, and were per-
formed using Graphpad Prism software.
Availability of supporting data
All microarray data were deposited into the ArrayEx-
press database (E-MTAB-1922). Other supporting data
are available as additional files.
Additional files
Additional file 1: Table S1. List of differentially expressed genes in
P. gingivalis treated samples.
Additional file 2: Figure S1. Visualization of the sequence annotation
and relative expression level using CIRCOS. The outer layer shows the
chromosomes and the band of chromosomes. The second layer refers
to the down-regulated sequences (in green) and the up-regulated
sequences (in red). The light lines of the third layer refer to the significantly
differentially expressed sequences. The gene names of the significantly
down-regulated sequences are shown in blue color and the gene names of
the significantly up-regulated sequences are shown in black color.
Additional file 3: Table S2. Up-regulated genes in AoSMCs stimulated
by P. gingivalis with a positive regulation of cell proliferation.
Additional file 4: Table S3. Down-regulated genes in AoSMCs
stimulated by P. gingivalis with a negative regulation of cell proliferation.
Additional file 5: Table S4. KEGG pathways for 28 up-regulated genes
related to the GO term of positive regulation of cell proliferation and 21
down-regulated genes related to the GO term of negative regulation of
cell proliferation analyzed by SPIA (FDR < 0.05).
Additional file 6: Figure S2. SPIA analysis on up-regulated genes in
AoSMCs exposed to P. gingivalis. X-axis indicates probability to observe
differentially expressed genes on the pathway; y-axis refers to the probability
to observe perturbation of genes within pathways. Each number refers to
a KEGG pathway ID. Pathways above the blue line are significant at 5%
after FDR correction, those above the red lines are significant at 5% after
Bonferroni correction.438 up-regulated genes were analyzed by SPIA analysis.
The Notch pathway is shown as a yellow dot and TGF-beta pathway is
shown as a green dot.
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